BIIB vs NTIC · P/E 21, rev $9.89B vs rev $84.2M
Biogen Inc (BIIB) versus Northern Technologies (NTIC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Northern Technologies (NTIC) is a specialty chemicals company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported NTIC revenue for 2025-08-31 was $84.2M. Net income was $986.4K. Revenue was down 1.0% from 2024-08-31 to 2025-08-31. NTIC currently screens at market cap $74.8M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. NTIC currently screens at market cap $74.8M.
Not investment advice. Open the BIIB and NTIC stock pages for the full models.
Not investment advice.